GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (OTCPK:CBSTF) » Definitions » 3-Year ROIIC %

CBSTF (Cannabist Company Holdings) 3-Year ROIIC % : 274.39% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Cannabist Company Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 274.39%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Cannabist Company Holdings's 3-Year ROIIC % or its related term are showing as below:

CBSTF's 3-Year ROIIC % is ranked better than
94.79% of 998 companies
in the Drug Manufacturers industry
Industry Median: 0.915 vs CBSTF: 274.39

Cannabist Company Holdings 3-Year ROIIC % Historical Data

The historical data trend for Cannabist Company Holdings's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings 3-Year ROIIC % Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial - - - 5.26 274.39

Cannabist Company Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 274.39 - - -

Competitive Comparison of Cannabist Company Holdings's 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's 3-Year ROIIC % falls into.



Cannabist Company Holdings 3-Year ROIIC % Calculation

Cannabist Company Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -20.2489737 (Dec. 2023) - -70.6507296 (Dec. 2020) )/( 666.823 (Dec. 2023) - 680.403 (Dec. 2020) )
=50.4017559/-13.58
=-371.15%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Cannabist Company Holdings  (OTCPK:CBSTF) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Cannabist Company Holdings 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under ClaraCeed, Seed & Starin, and Triple 777 brands among others.
Executives
David Sirolly officer: Chief Legal Officer/GC C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Julie A Hill director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Jeff Clarke director COMPUTER ASSOCIATES INTERNATIONAL INC, ONE COMPUTER ASSOCIATES PLAZA, ISLANDA NY 11746
Derek Watson officer: Chief Financial Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
David James Hart officer: Chief Operating Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Alison Worthington director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Bryan Olson officer: Chief People/Admin Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Nicholas Vita director, officer: Chief Executive Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Rosemary Mazanet officer: Chief Scientific Officer 175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS TN 38103
Guy Hussussian officer: Chief Data Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Jesse Channon officer: Chief Growth Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Michael Abbott director, officer: Chairman C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Philip Goldberg director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Frank Savage director
Kennedy James A C director T ROWE PRICE GROUP INC, 100 E PRATT ST, BALTIMORE MD 21202

Cannabist Company Holdings Headlines

From GuruFocus

Columbia Care Inc Business Update Call Transcript

By GuruFocus Research 02-13-2024

Q4 2020 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2022 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Columbia Care Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q2 2021 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2022 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2022 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024